iX Biopharma to sell Chemical Analysis unit for A$12.5m


IX Biopharma has entered into an agreement with independent third party Eurofins Australia New Zealand Holding for the proposed disposal of its entire stake in its wholly owned subsidiary, Chemical Analysis, for A$12.5 million (S$12 million) in cash.

The company expects to receive net proceeds...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to